Literature DB >> 17509453

HLA-A, -B, -C, and -DRB1 allele frequencies in Cuban individuals with antecedents of dengue 2 disease: advantages of the Cuban population for HLA studies of dengue virus infection.

Beatriz Sierra1, Roberto Alegre, Ana B Pérez, Gissel García, Katharina Sturn-Ramirez, Olugbenga Obasanjo, Eglys Aguirre, Mayling Alvarez, Rosmari Rodriguez-Roche, Luis Valdés, Phyllis Kanki, María G Guzmán.   

Abstract

Dengue virus infection has emerged as one of the most important arthropod-borne diseases. In some dengue-infected individual, the disease progresses to its severe, life-threatening form, dengue hemorrhagic fever (DHF). Host genetic factors may be relevant and predispose some individuals to the severe dengue disease. The unique history of dengue outbreaks in Cuba is extremely advantageous for genetic studies of dengue disease resistance or susceptibility. Consequently, samples collected from 120 healthy individuals that developed dengue fever (DF) and DHF during the 1997 dengue 2 outbreak in the Santiago de Cuba municipality were HLA genotyped using polymerase chain reaction-sequence-specific primers. Polymorphism at the human leukocyte antigen (HLA) class I loci was significantly associated with DHF disease susceptibility, but polymorphism in the HLA-DRB1 was associated with protection. Amino acid peptides present in the poly-protein of the dengue 2 Jamaica strain, which are able to bind to the HLA class I and class II allotypes associated with susceptibility to or protection against the dengue clinical disease, respectively, were predicted using the BIMAS and SYFPEITHI predictive algorithms of peptide/MHC interaction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17509453     DOI: 10.1016/j.humimm.2007.03.001

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  37 in total

1.  Reply: Apropos "Dengue virus identification by transmission electron microscopy and molecular methods in fatal dengue hemorrhagic fever".

Authors:  D Limonta; V Capó; M G Guzmán
Journal:  Infection       Date:  2013-02-09       Impact factor: 3.553

2.  Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells.

Authors:  Daniela Weiskopf; Michael A Angelo; Elzinandes L de Azeredo; John Sidney; Jason A Greenbaum; Anira N Fernando; Anne Broadwater; Ravi V Kolla; Aruna D De Silva; Aravinda M de Silva; Kimberly A Mattia; Benjamin J Doranz; Howard M Grey; Sujan Shresta; Bjoern Peters; Alessandro Sette
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-11       Impact factor: 11.205

Review 3.  Pharmacogenetic research activity in Central America and the Caribbean: a systematic review.

Authors:  Carolina Céspedes-Garro; María-Eugenia G Naranjo; Fernanda Rodrigues-Soares; Adrián LLerena; Jorge Duconge; Lazara K Montané-Jaime; Hilda Roblejo; Humberto Fariñas; María de Los A Campos; Ronald Ramírez; Víctor Serrano; Carmen I Villagrán; Eva M Peñas-LLedó
Journal:  Pharmacogenomics       Date:  2016-09-16       Impact factor: 2.533

Review 4.  Dengue virus life cycle: viral and host factors modulating infectivity.

Authors:  Izabela A Rodenhuis-Zybert; Jan Wilschut; Jolanda M Smit
Journal:  Cell Mol Life Sci       Date:  2010-04-06       Impact factor: 9.261

5.  Dengue hemorrhagic fever is associated with polymorphisms in JAK1.

Authors:  Luciano K Silva; Ronald E Blanton; Antonio R Parrado; Paulo S Melo; Vanessa G Morato; Eliana A G Reis; Juarez P Dias; Jesuina M Castro; Pedro F C Vasconcelos; Katrina A B Goddard; Maurício L Barreto; Mitermayer G Reis; M Glória Teixeira
Journal:  Eur J Hum Genet       Date:  2010-06-30       Impact factor: 4.246

6.  Dynamics of dengue disease severity determined by the interplay between viral genetics and serotype-specific immunity.

Authors:  Molly OhAinle; Angel Balmaseda; Alexander R Macalalad; Yolanda Tellez; Michael C Zody; Saira Saborío; Andrea Nuñez; Niall J Lennon; Bruce W Birren; Aubree Gordon; Matthew R Henn; Eva Harris
Journal:  Sci Transl Med       Date:  2011-12-21       Impact factor: 17.956

7.  Serotype-specific differences in the risk of dengue hemorrhagic fever: an analysis of data collected in Bangkok, Thailand from 1994 to 2006.

Authors:  Jessica R Fried; Robert V Gibbons; Siripen Kalayanarooj; Stephen J Thomas; Anon Srikiatkhachorn; In-Kyu Yoon; Richard G Jarman; Sharone Green; Alan L Rothman; Derek A T Cummings
Journal:  PLoS Negl Trop Dis       Date:  2010-03-02

8.  Susceptible and protective HLA class 1 alleles against dengue fever and dengue hemorrhagic fever patients in a Malaysian population.

Authors:  Ramapraba Appanna; Sasheela Ponnampalavanar; Lucy Lum Chai See; Shamala Devi Sekaran
Journal:  PLoS One       Date:  2010-09-28       Impact factor: 3.240

9.  HLA class II allele polymorphism in an outbreak of chikungunya fever in Middle Andaman, India.

Authors:  Itta Krishna Chaaithanya; Nagarajan Muruganandam; Maile Anwesh; Reesu Rajesh; Sruti R Ghosal; Chinnaiah Kartick; Kadiyala Nageswara Prasad; Karuppiah Muthumani; Paluru Vijayachari
Journal:  Immunology       Date:  2013-10       Impact factor: 7.397

10.  Gene expression profiling during early acute febrile stage of dengue infection can predict the disease outcome.

Authors:  Eduardo J M Nascimento; Ulisses Braga-Neto; Carlos E Calzavara-Silva; Ana L V Gomes; Frederico G C Abath; Carlos A A Brito; Marli T Cordeiro; Ana M Silva; Cecilia Magalhães; Raoni Andrade; Laura H V G Gil; Ernesto T A Marques
Journal:  PLoS One       Date:  2009-11-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.